Published in J Clin Invest on November 01, 1939
Anaemia of rheumatoid arthritis. Ann Rheum Dis (1952) 3.11
Iron metabolism; hematopoiesis following phlebotomy; iron as a limiting factor. J Clin Invest (1950) 2.35
Plasma volume in cirrhosis of the liver: its relation of portal hypertension, ascites, and renal failure. J Clin Invest (1967) 1.78
PLASMA PROTEIN AND HEMOGLOBIN IN THE PROTEIN-DEFICIENT RAT. A THREE-DIMENSIONAL STUDY. J Clin Invest (1945) 1.37
Blood volume in health and disease. Bull N Y Acad Med (1954) 1.30
HYPERVOLEMIC ANEMIA IN CIRRHOSIS. J Clin Invest (1949) 1.06
Cardiac output and blood volume in severe hookworm anaemia. Br Heart J (1962) 0.89
The relation of blood volume to body weight and arterial haemoglobin levels in rabbits. J Physiol (1967) 0.85
Mechanism of oedema in chronic severe anaemia. Br Heart J (1963) 0.79
Discussion on anaemia in rheumatoid arthritis. Proc R Soc Med (1956) 0.75
"Chronic oligemia" in surgical patients. Ann Surg (1961) 0.75
The cardiovascular adjustments in anaemia: a review. Can Med Assoc J (1954) 0.75
Haemodilution in rheumatoid disease. Ann Rheum Dis (1956) 0.75
CLINICAL STUDIES OF THE BLOOD VOLUME. I. CLINICAL APPLICATION OF A METHOD EMPLOYING THE AZO DYE "EVANS BLUE" AND THE SPECTROPHOTOMETER. J Clin Invest (1937) 84.46
CLINICAL STUDIES OF THE BLOOD VOLUME. II. THE RELATION OF PLASMA AND TOTAL BLOOD VOLUME TO VENOUS PRESSURE, BLOOD VELOCITY RATE, PHYSICAL MEASUREMENTS, AGE AND SEX IN NINETY NORMAL HUMANS. J Clin Invest (1937) 47.11
CLINICAL STUDIES OF THE BLOOD VOLUME. III. CHANGES IN BLOOD VOLUME, VENOUS PRESSURE AND BLOOD VELOCITY RATE IN CHRONIC CONGESTIVE HEART FAILURE. J Clin Invest (1937) 16.41
PULMONARY GAS DIFFUSION IN POLYCYTHEMIA VERA. J Clin Invest (1927) 7.68
STUDIES ON THE VELOCITY OF BLOOD FLOW: XV. The Velocity of Blood Flow and Other Aspects of the Circulation in Patients with "Primary" and Secondary Anemia and in Two Patients with Polycythemia Vera. J Clin Invest (1931) 3.80
CLINICAL STUDIES OF THE BLOOD VOLUME. VI. CHANGES IN BLOOD VOLUME IN PERNICIOUS ANEMIA IN RELATION TO THE HEMATOPOIETIC RESPONSE TO INTRA-MUSCULAR LIVER EXTRACT THERAPY. J Clin Invest (1939) 2.82
CLINICAL STUDIES OF THE BLOOD VOLUME. VII. CHANGES IN BLOOD VOLUME IN BRIGHT'S DISEASE WITH OR WITHOUT EDEMA, RENAL INSUFFICIENCY, OR CONGESTIVE HEART FAILURE, AND IN HYPERTENSION. J Clin Invest (1939) 2.30
STUDIES ON THE CIRCULATION IN PREGNANCY. I. THE VELOCITY OF BLOOD FLOW AND RELATED ASPECTS OF THE CIRCULATION IN NORMAL PREGNANT WOMEN. J Clin Invest (1936) 1.02
CLINICAL STUDIES OF THE BLOOD VOLUME. I. CLINICAL APPLICATION OF A METHOD EMPLOYING THE AZO DYE "EVANS BLUE" AND THE SPECTROPHOTOMETER. J Clin Invest (1937) 84.46
CLINICAL STUDIES OF THE BLOOD VOLUME. II. THE RELATION OF PLASMA AND TOTAL BLOOD VOLUME TO VENOUS PRESSURE, BLOOD VELOCITY RATE, PHYSICAL MEASUREMENTS, AGE AND SEX IN NINETY NORMAL HUMANS. J Clin Invest (1937) 47.11
CLINICAL STUDIES OF THE BLOOD VOLUME. III. CHANGES IN BLOOD VOLUME, VENOUS PRESSURE AND BLOOD VELOCITY RATE IN CHRONIC CONGESTIVE HEART FAILURE. J Clin Invest (1937) 16.41
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (1986) 14.56
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell (1991) 8.27
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature (1990) 5.63
Mouse myelomas and lymphomas in culture. Exp Cell Res (1970) 5.12
Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A (1991) 4.72
Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J (1995) 4.68
DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell (1994) 4.22
The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell (1986) 3.72
CLINICAL STUDIES OF THE BLOOD VOLUME. V. HYPERTHYROIDISM AND MYXEDEMA. J Clin Invest (1939) 3.46
Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci U S A (1999) 3.45
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J (1994) 2.91
A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J (1998) 2.82
CLINICAL STUDIES OF THE BLOOD VOLUME. VI. CHANGES IN BLOOD VOLUME IN PERNICIOUS ANEMIA IN RELATION TO THE HEMATOPOIETIC RESPONSE TO INTRA-MUSCULAR LIVER EXTRACT THERAPY. J Clin Invest (1939) 2.82
Expression of the immunoglobulin C mu gene in mouse T and B lymphoid and myeloid cell lines. Proc Natl Acad Sci U S A (1980) 2.57
Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines. J Immunol (1983) 2.30
bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis. Oncogene (1993) 2.25
Cell-mediated immune response in vitro. II. The role of thymus and thymus-derived lymphocytes. Cell Immunol (1972) 2.15
Differentiated functions expressed by cultured mouse lymphoma cells. II. Theta antigen, surface immunoglobulin and a receptor for antibody on cells of a thymoma cell line. J Immunol (1973) 2.14
Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment. Blood (1999) 2.06
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00
Transcripts of the immunoglobulin C mu gene vary in structure and splicing during lymphoid development. Proc Natl Acad Sci U S A (1980) 1.89
Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev (1996) 1.89
Bcl-2 expression promotes B- but not T-lymphoid development in scid mice. Nature (1994) 1.88
Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr Top Microbiol Immunol (1990) 1.86
Effect of cloned interferon-gamma on expression of H-2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin. Eur J Immunol (1984) 1.73
Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment. Blood (1998) 1.70
N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc. EMBO J (1989) 1.65
Subunit structure of cell surface proteins: disulfide bonding in antigen receptors, Ly-2/3 antigens, and transferrin receptors of murine T and B lymphocytes. Proc Natl Acad Sci U S A (1981) 1.58
Glucocorticoid receptors in lymphoma cells in culture: relationship to glucocorticoid killing activity. Science (1971) 1.56
E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene (1993) 1.51
Mechanism of glucocorticoid action: general features, with reference to steroid-mediated immunosuppression. Transplant Proc (1975) 1.42
Mutations in bacteriophage lambda affecting particle morphogenesis. Virology (1968) 1.42
Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J Exp Med (1997) 1.41
Immunoglobulin of T lymphoma cells. Biosynthesis, surface representation, and partial characterization. Biochemistry (1975) 1.39
FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor. EMBO J (2000) 1.38
An investigation of the efficiency of the oral airway and a technique for improving the airway in the early post-operative period following mandibular osteotomy. Br J Oral Surg (1970) 1.36
Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation. Cancer Res (1999) 1.35
Differential expression of the invariant chain in mouse tumor cells: relationship to B lymphoid development. J Immunol (1984) 1.33
An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene. EMBO J (1990) 1.32
Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene. Proc Natl Acad Sci U S A (1994) 1.32
Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell (1995) 1.28
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector. Oncogene (1999) 1.24
Production of RNA for secreted immunoglobulin mu chains does not require transcriptional termination 5' to the microM exons. Nature (1983) 1.24
Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields. Radiat Res (1997) 1.23
Progenitor tumours from Emu-bcl-2-myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival. EMBO J (1996) 1.22
The immunoglobulin mu constant region gene is expressed in mouse thymocytes. Nature (1980) 1.19
Activation of mouse lymphocytes inhibits induction of rapid cell death by x-irradiation. J Immunol (1985) 1.16
Generation of long mRNA for membrane immunoglobulin gamma 2a chains by differential splicing. Nature (1981) 1.13
Expression of a bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo. J Immunol (1997) 1.11
Norethisterone jaundice in two sisters. Br Med J (1968) 1.10
Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc. Oncogene (1992) 1.10
A bcr-v-abl oncogene induces lymphomas in transgenic mice. Mol Cell Biol (1989) 1.10
Differentiated functions expressed by cultured mouse lymphoma cells. I. Specificity and kinetics of cell responses to corticosteroids. Exp Cell Res (1970) 1.07
Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells. Curr Biol (2001) 1.06
Receptors for immunoglobulin on B lymphocytes and cells of a cultured plasma cell tumor. J Immunol (1972) 1.05
bcl-2 transgene expression promotes survival and reduces proliferation of CD3-CD4-CD8- T cell progenitors. Int Immunol (1997) 1.05
The coronally positioned pedicle graft with inlaid margins: a predictable method of obtaining root coverage of shallow defects. Int J Periodontics Restorative Dent (1994) 1.03
Intermediate steps in thymic positive selection. Generation of CD4-8+ T cells in culture from CD4+8+, CD4int8+, and CD4+8int thymocytes with up-regulated levels of TCR-CD3. J Immunol (1995) 1.01
CD4+8- and CD4-8+ mature thymocytes require different post-selection processing for final development. J Immunol (1993) 1.01
Immunoglobulin production by murine B-lymphoma cells. Clin Immunol Immunopathol (1981) 1.01
Immunoglobulin Cmu RNA in T lymphoma cells is not translated. Nature (1980) 0.98
Molecular properties of T lymphoma immunoglobulin. I. Serological and general physicochemical properties. J Immunogenet (1977) 0.97
Detection of a possible precursor of immunoglobulin light chain in MOPC 41 A plasmacytoma cells. FEBS Lett (1975) 0.96
Alkaline phosphatase in hematopoietic tumor cell lines of the mouse: high activity in cells of the B lymphoid lineage. J Immunol (1981) 0.96
Subversion of the Bcl-2 life/death switch in cancer development and therapy. Cold Spring Harb Symp Quant Biol (2005) 0.95
Overexpressed max is not oncogenic and attenuates myc-induced lymphoproliferation and lymphomagenesis in transgenic mice. Oncogene (1995) 0.94
Acceleration of B-lymphoid tumorigenesis in E mu-myc transgenic mice by v-H-ras and v-raf but not v-abl. Oncogene Res (1989) 0.94
Growth of E mu-myc transgenic B-lymphoid cells in vitro and their evolution toward autonomy. Oncogene Res (1988) 0.92
Transferrin promotion of 67Ga and 59Fe uptake by cultured mouse myeloma cells. Cancer Res (1977) 0.92
Transgenic mouse models for hematopoietic tumorigenesis. Curr Top Microbiol Immunol (1988) 0.92
Effect of thymidine on the sensitivity of cultured mouse tumor cells to 1-beta-D-arabinofuranosylcytosine. Cancer Res (1979) 0.90
Insights from transgenic mice regarding the role of bcl-2 in normal and neoplastic lymphoid cells. Philos Trans R Soc Lond B Biol Sci (1994) 0.90
Deoxyribonucleoside triphosphate pools and differential thymidine sensitivities of cultured mouse lymphoma and myeloma cells. Biochim Biophys Acta (1979) 0.89
Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteins. Cold Spring Harb Symp Quant Biol (1999) 0.88
Inhibition of a T-cell-dependent immune response in vitro by thymoma cell immunoglobulin. J Exp Med (1974) 0.87
mu Polypeptide phenotypes of lymphoid and myeloid cell lines containing RNA transcripts of the immunoglobulin C mu gene. J Immunol (1981) 0.87
Genetic studies on Emu-myc transgenic mice. Curr Top Microbiol Immunol (1988) 0.87
CD95 (Fas/APO-1) and p53 signal apoptosis independently in diverse cell types. Cancer Res (2000) 0.86
B-lymphoid to granulocytic switch during hematopoiesis in a transgenic mouse strain. Immunity (1994) 0.85
c-myc-induced lymphomagenesis in transgenic mice and the role of the Pvt-1 locus in lymphoid neoplasia. Curr Top Microbiol Immunol (1986) 0.85
Enhanced cell survival and tumorigenesis. Cold Spring Harb Symp Quant Biol (1994) 0.85
Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England. Aliment Pharmacol Ther (2008) 0.85
Gallium-67 citrate uptake by cultured tumor cells, stimulated by serum transferrin. J Natl Cancer Inst (1975) 0.85
The role of bcl-2 in lymphoid differentiation and neoplastic transformation. Curr Top Microbiol Immunol (1992) 0.84
Moloney virus induction of T-cell lymphomas in a plasmacytomagenic strain of E mu-v-abl transgenic mice. Int J Cancer (1993) 0.84
Ga-67 and Fe-59 distributions in mice. J Nucl Med (1978) 0.84
Formation of asteroid pairs by rotational fission. Nature (2010) 0.84
A B lymphoma cell line produces growth factors for hemopoietic, lymphoid, and mast cells. Cell Immunol (1982) 0.83
In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes. J Immunol (1972) 0.83
Helicobacter pylori and gastric metaplasia of the duodenum. Gut (1995) 0.82
The myc oncogene and lymphoid neoplasia: from translocations to transgenic mice. Haematol Blood Transfus (1987) 0.81
Plasma membrane of a murine T cell lymphoma: surface labelling, membrane isolation, separation of membrane proteins and distribution of surface label amongst these proteins. Aust J Exp Biol Med Sci (1976) 0.81
Effect of a bcl-2 transgene on production and localization of precursor B cells in mouse bone marrow. Exp Hematol (1998) 0.79
Lessons from bcl-2 transgenic mice for immunology, cancer biology and cell death research. Behring Inst Mitt (1996) 0.79
Duodenal ulcer, gastric acid, and Helicobacter pylori. Gut (1995) 0.78
Perturbed development of T and B cells in mice expressing an Hlx homeobox transgene. J Immunol (1995) 0.78